In the past couple of years, the UK has witnessed a revolution in healthcare pounds‑reduction treatments — from your introduction of semaglutide (Wegovy®) to your growing attractiveness of tirzepatide (Mounjaro®). Now, A different identify is drawing awareness in the two medical and general publi